Dementia poses challenges for families, yet Bruce Willis’ ex-wife, Demi Moore, declares her unwavering commitment to stand by him through his struggle with frontotemporal dementia.
The 69-year-old renowned action star, famous for his role in the iconic 1989 film Die Hard, retired from acting in 2022 following a diagnosis of aphasia, later confirmed to be frontotemporal dementia.
Frontotemporal dementia leads to cognitive decline and declining health, creating a daunting experience for the individual with the illness and their loved ones, however, Bruce can rely on Demi for unwavering support.
“Demi has made a promise to stand beside him. She feels his pain as he battles this devastating disease,” a source shared with RadarOnline.com. “Demi understands the preciousness of time.”
The insider further revealed, “She is steadfast in her commitment to him.”
The couple tied the knot in November 1987 and raised three children together, now grown-up. Rumer Willis (35) is the eldest, followed by Scout (33) and Tallulah (30), all offering their support to their father.
Despite Moore and Willis parting ways in 2000, there is a harmonious relationship as she continues to offer support to his current spouse, Emma Heming, and their two children, Mabel (12) and Evelyn (10).
Overview of Frontotemporal Dementia
Frontotemporal dementia (FTD) encompasses a range of brain disorders resulting from progressive damage to the frontal and temporal lobes, impacting personality, behavior, and language. There is currently no cure, with treatment aimed at symptom management and enhancing life quality.
Distinct from Alzheimer’s, which mainly affects memory, FTD often manifests as notable changes in social behavior, emotional control, and communication, leading to symptoms like inappropriate actions, speech difficulties, and impaired judgment.
Typically appearing earlier, often in individuals in their 50s or 60s, FTD comprises various subtypes, each with unique features. Diagnosis involves clinical assessment, neuroimaging, and occasionally genetic testing.